Stefan Groß

3.9k total citations · 1 hit paper
52 papers, 2.8k citations indexed

About

Stefan Groß is a scholar working on Molecular Biology, Cell Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Stefan Groß has authored 52 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 12 papers in Cell Biology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Stefan Groß's work include Microtubule and mitosis dynamics (10 papers), Cancer Mechanisms and Therapy (7 papers) and Reproductive Biology and Fertility (6 papers). Stefan Groß is often cited by papers focused on Microtubule and mitosis dynamics (10 papers), Cancer Mechanisms and Therapy (7 papers) and Reproductive Biology and Fertility (6 papers). Stefan Groß collaborates with scholars based in United States, Germany and Austria. Stefan Groß's co-authors include Richard A. Anderson, Claire Moore, James L. Maller, Andrea L. Lewellyn, Markus S. Schwab, Frédéric Taïeb, Rami Rahal, Klaus P. Hoeflich, Christoph Lengauer and Nicolas Stransky and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Stefan Groß

50 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting cancer with kinase inhibitors

2015 335 citations Stefan Groß et al. profile →

Peers

Stefan Groß

ONCOL

PHEOH

Angela Ogden United States

Alejandro Gutiérrez United States

Satoshi Tashiro Japan

Robert J. Hickey United States

Hsin‐Shih Wang Taiwan

Federica Gibellini United States

Linda H. Malkas United States

Isabel Domínguez United States

Guido J.R. Zaman Netherlands

Lou A. Smets Netherlands

Angela Ogden United States

Stefan Groß

1.5k ×0.7

452 ×0.8

575 ×1.2

ONCOL

218 ×0.6

PHEOH

45 ×0.2

Citations per year, relative to Stefan Groß Stefan Groß (= 1×) peers Angela Ogden

Countries citing papers authored by Stefan Groß

Since Specialization

Citations

This map shows the geographic impact of Stefan Groß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Groß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Groß more than expected).

Fields of papers citing papers by Stefan Groß

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Groß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Groß. The network helps show where Stefan Groß may publish in the future.

Co-authorship network of co-authors of Stefan Groß

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Groß. A scholar is included among the top collaborators of Stefan Groß based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Groß. Stefan Groß is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yiheng, Chih‐Jen Yang, Jiaqing Pang, et al.. (2024). Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet function. Journal of Pharmacology and Experimental Therapeutics. 392(1). 100020–100020. 1 indexed citations

Groß, Stefan, Marie Süße, Pavel Hok, et al.. (2023). Polypharmacy in patients with multiple sclerosis and the impact on levels of care and therapy units. Frontiers in Neurology. 14. 1330066–1330066.

Grothe, Matthias, Stefan Groß, Marie Süße, Sebastian Strauß, & Iris‐Katharina Penner. (2022). The Seasonal Fluctuation of Fatigue in Multiple Sclerosis. Frontiers in Neurology. 13. 900792–900792. 11 indexed citations

Davies, Kurtis D., P. LouAnn Cable, Jennifer Garrus, et al.. (2011). Chk1 inhibition and Wee1 inhibition combine synergistically to impede cellular proliferation. Cancer Biology & Therapy. 12(9). 788–796. 67 indexed citations

Kallan, Nicholas C., Keith L. Spencer, James F. Blake, et al.. (2011). Discovery and SAR of spirochromane Akt inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(8). 2410–2414. 33 indexed citations

Davies, Kurtis D., Michael Humphries, Francis X. Sullivan, et al.. (2011). Single-Agent Inhibition of Chk1 Is Antiproliferative in Human Cancer Cell Lines In Vitro and Inhibits Tumor Xenograft Growth In Vivo. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 19(7). 349–363. 22 indexed citations

Fathi, Amir T., Omotayo Arowojolu, Takashi Sato, et al.. (2011). A potential therapeutic target for FLT3-ITD AML: PIM1 kinase. Leukemia Research. 36(2). 224–231. 47 indexed citations

Wright, Dale, Stefan Groß, John Robinson, et al.. (2009). Inhibition of T cell function in vitro and in vivo using small molecule antagonists of PIM kinases (35.33). The Journal of Immunology. 182(Supplement_1). 35.33–35.33. 1 indexed citations

Bouhana, Karyn, Deborah Anderson, Jennifer Garrus, et al.. (2009). Abstract #1795: In Vitro and in vivo activity of ARRY-380: A potent, small molecule inhibitor of ErbB2.. Cancer Research. 69. 1795–1795. 20 indexed citations

10.

Groß, Stefan, et al.. (2008). Identification of CHO Endogenous Promoter Elements Based on a Genomic Library Approach. Molecular Biotechnology. 39(2). 135–139. 13 indexed citations

11.

Yeh, Tammie C., Vivienne Marsh, Bryan A. Bernat, et al.. (2007). Biological Characterization of ARRY-142886 (AZD6244), a Potent, Highly Selective Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor. Clinical Cancer Research. 13(5). 1576–1583. 442 indexed citations

12.

Grillari‐Voglauer, Regina, Regina Voglauer, Stefan Groß, et al.. (2005). Establishment of a strategy for the rapid generation of a monoclonal antibody against the human protein SNEV (hNMP200) by flow-cytometric cell sorting. Journal of Immunological Methods. 307(1-2). 13–23. 7 indexed citations

13.

Maller, James L., Markus S. Schwab, Stefan Groß, et al.. (2002). The mechanism of CSF arrest in vertebrate oocytes. Molecular and Cellular Endocrinology. 187(1-2). 173–178. 31 indexed citations

14.

Groß, Stefan & Claire Moore. (2001). Rna15 Interaction with the A-Rich Yeast Polyadenylation Signal Is an Essential Step in mRNA 3′-End Formation. Molecular and Cellular Biology. 21(23). 8045–8055. 78 indexed citations

15.

Taïeb, Frédéric, Stefan Groß, Andrea L. Lewellyn, & James L. Maller. (2001). Activation of the anaphase-promoting complex and degradation of cyclin B is not required for progression from Meiosis I to II in Xenopus oocytes. Current Biology. 11(7). 508–513. 104 indexed citations

16.

Maller, James L., Markus S. Schwab, B.Tibor Roberts, et al.. (2001). The pathway of MAP kinase mediation of CSF arrest in Xenopus oocytes. Biology of the Cell. 93(1-2). 27–33. 22 indexed citations

17.

Groß, Stefan, Markus S. Schwab, Frédéric Taïeb, et al.. (2000). The critical role of the MAP kinase pathway in meiosis II in Xenopus oocytes is mediated by p90Rsk. Current Biology. 10(8). 430–438. 199 indexed citations

18.

Groß, Stefan & Richard A. Anderson. (1998). Casein Kinase I. Cellular Signalling. 10(10). 699–711. 262 indexed citations

19.

Kessler, Marco M., Michael F. Henry, Jing Zhao, et al.. (1997). Hrp1, a sequence-specific RNA-binding protein that shuttles between the nucleus and the cytoplasm, is required for mRNA 3′-end formation in yeast. Genes & Development. 11(19). 2545–2556. 198 indexed citations

20.

Auerswald, Ennes A., Dorit K. Nägler, Stefan Groß, et al.. (1996). Hybrids of Chicken Cystatin with Human Kininogen Domain 2 Sequences Exhibit Novel Inhibition of Calpain, Improved Inhibition of Actinidin and Impaired Inhibition of Papain, Cathepsin L and Cathepsin B. European Journal of Biochemistry. 235(3). 534–542. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact